The Anti-FLT1(icrucumab biosimilar) mAb Antibody from DIMA Biotechnology Ltd. is a Human Monoclonal antibody to FLT1, and Fms related receptor tyrosine kinase 1. This antibody recognizes Human antigen. The Anti-FLT1(icrucumab biosimilar) mAb Antibody has been validated for the following applications: EIA, Immunoassay, ELISA, and Flow Cytometry.